Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 14.31 4.91% 0.67
ATRA closed up 4.91 percent on Thursday, April 22, 2021, on 81 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical ATRA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Slingshot Bearish Bearish Swing Setup 4.91%
Lower Bollinger Band Walk Weakness 4.91%
Outside Day Range Expansion 4.91%
Lower Bollinger Band Touch Weakness 4.91%
Oversold Stochastic Weakness 4.91%
Lower Bollinger Band Walk Weakness 7.67%
Outside Day Range Expansion 7.67%
Older End-of-Day Signals for ATRA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR about 16 hours ago
Up 5% about 17 hours ago
Rose Above 20 DMA about 17 hours ago
Up 3% about 17 hours ago
60 Minute Opening Range Breakout about 18 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Clinical Development Solid Tumors Drugs Ovarian Cancer Targeted Therapy Renal Disease End Stage Renal Disease Stage Renal Disease

Is ATRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.2
52 Week Low 7.45
Average Volume 756,915
200-Day Moving Average 16.40
50-Day Moving Average 15.72
20-Day Moving Average 14.06
10-Day Moving Average 13.70
Average True Range 0.76
ADX 25.51
+DI 18.95
-DI 21.30
Chandelier Exit (Long, 3 ATRs ) 13.08
Chandelier Exit (Short, 3 ATRs ) 15.13
Upper Bollinger Band 15.02
Lower Bollinger Band 13.10
Percent B (%b) 0.63
BandWidth 13.66
MACD Line -0.60
MACD Signal Line -0.71
MACD Histogram 0.1102
Fundamentals Value
Market Cap 1.11 Billion
Num Shares 77.7 Million
EPS -6.07
Price-to-Earnings (P/E) Ratio -2.36
Price-to-Sales 0.00
Price-to-Book 5.14
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.80
Resistance 3 (R3) 15.69 15.09 15.55
Resistance 2 (R2) 15.09 14.71 15.14 15.46
Resistance 1 (R1) 14.70 14.48 14.90 14.81 15.38
Pivot Point 14.10 14.10 14.20 14.15 14.10
Support 1 (S1) 13.71 13.72 13.91 13.82 13.24
Support 2 (S2) 13.11 13.49 13.16 13.16
Support 3 (S3) 12.72 13.11 13.07
Support 4 (S4) 12.83